Skip to main content
Premium Trial:

Request an Annual Quote

Epistem Partners with USAF, Hopkins to Evaluate MDx System for Combat

NEW YORK (GenomeWeb News) — Epistem said yesterday that it has entered into cooperative agreements with the US Air Force and Johns Hopkins University's Advanced Physics Laboratory to undertake combat evaluation of Epistem's Genedrive molecular handheld pathogen-detection device.

The agreement provides Manchester, UK-based Epistem with $600,000 over five months to develop and evaluate Genedrive for the identification of three known disease pathogens.

Successful completion of the combat evaluation program will secure ongoing investment for Genedrive's development as a handheld pathogen-detection unit for the US Department of Defense, Epistem said.

Genedrive is a fully integrated, handheld, endpoint PCR-based system that weighs around a pound and has a footprint similar to that of a laptop computer.

The company said this week that it is preparing to launch the first Genedrive test for tuberculosis this year, and it is currently readying the final stages of clinical trials to support Indian regulatory approval.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.